Biodexa Pharmaceuticals (BDRX) Research & Development (2013 - 2026)
Biodexa Pharmaceuticals' Research & Development came in at -$3.91 million for the quarter ended Jun 30, 2026, compared with -$2.22 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biodexa Pharmaceuticals reported Research & Development of -$11.16 million; for the year ended Dec 31, 2025, it came in at -$5.22 million.
- Going back by year, Research & Development was -$6.95 million in the year ended Dec 31, 2024, -$5.06 million in the year ended Dec 31, 2023, -$6.33 million in the year ended Dec 31, 2022 and -$6.4 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Research & Development since the quarter ended Dec 31, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Biodexa Pharmaceuticals | 41.06 Mn | 17.85 Mn | - | -3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.91 Mn |
| Dec 31, 2025 | -2.21 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Jun 30, 2023 | -2.82 Mn |
| Dec 31, 2022 | -2.83 Mn |
| Dec 31, 2020 | -8.01 Mn |
| Dec 31, 2019 | -10.08 Mn |
| Dec 31, 2018 | -12.04 Mn |
| Dec 31, 2017 | -472,648.68 |
| Dec 31, 2016 | -10.99 Mn |
| Dec 31, 2015 | -15.46 Mn |
| Dec 31, 2014 | -5.77 Mn |
| Dec 31, 2013 | -3.12 Mn |
API Access
Biodexa Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();